The arginine-rich RNA-binding domain of bovine immunode®ciency virus (BIV) Tat adopts a b-hairpin conformation upon binding to the major groove of BIV TAR. Based on its NMR structure, we modeled dimeric arrangements in which two adjacent TAR sites might be recognized with high af®nity by a dimeric peptide. Some dimeric RNAs ef®ciently bound two unlinked BIV Tat peptides in vitro, but could not bind even one monomeric peptide in vivo, as monitored by transcriptional activation of human immunode®ciency virus long terminal repeat reporters. Results with additional reporters suggest that extending the RNA helix in the dimeric arrangements inhibits peptide binding by decreasing major groove accessibility. In contrast, a dimeric peptide ef®ciently bound an optimally arranged dimeric TAR in vivo, and bound with an af®nity at least 10-fold higher than the monomeric peptide in vitro. Mutating speci®c nucleotides in each RNA`half-site' or speci®c amino acids in each b-hairpin of the dimeric peptide substantially decreased binding af®nity, providing evidence for the modeled dimer±dimer interaction. These studies provide a starting point for identifying dimeric RNA±protein interactions with even higher binding af®nities and speci®cities.
Introduction
The large body of structural information on DNA±protein complexes has made it possible over the past few years to utilize structure-based approaches to design sequencespeci®c DNA-binding molecules that might be used to control the expression of speci®c genes. Two of the most successful examples involve the use of zinc ®nger proteins to target the DNA major groove and polyamides to target the DNA minor groove (for recent reviews see Dervan and Burli, 1999; Segal and Barbas, 2000) . Most of the strategies have combined information from highresolution structures with combinatorial experiments to help identify the tightest and most speci®c binders. In addition to targeting DNA, in some cases it also may be desirable to target speci®c RNA elements involved in transcriptional, post-transcriptional or other RNA-based processes. Structure-based design of RNA binders is currently more dif®cult than for DNA because fewer structures of RNA±protein complexes have been solved and because the greater structural diversity of RNA makes the`rules' of recognition more complex (Draper, 1999; Hermann and Patel, 1999; Hermann and Westhof, 1999) . Nevertheless, some promising approaches have been identi®ed, with much of the effort to date focused on using aminoglycoside or peptide scaffolds to design speci®c RNA binders (for recent reviews see Walter et al., 1999; Frankel, 2000) . We have been particularly interested in using arginine-rich peptides for this purpose.
Arginine-rich RNA-binding domains are found in a relatively large group of proteins and often can speci®cally recognize their RNA targets even as short (<20 amino acid), isolated peptides (Frankel, 2000) . The structures of several RNA±peptide model systems have been solved by NMR and illustrate the wide variety of ways in which speci®c RNA sites can be recognized by small peptides or proteins. Arginine-rich peptides from human immunode®ciency virus (HIV) Rev, and bacteriophage l and P22 N proteins recognize internal or terminal RNA loops using a-helical or bent helical conformations, a bovine immunode®ciency virus (BIV) Tat peptide recognizes an RNA bulge using a b-hairpin conformation and an HIV Tat peptide recognizes an RNA bulge using an apparently extended conformation (Calnan et al., 1991; Tan et al., 1993; Aboul-ela et al., 1995; Puglisi et al., 1995; Tan and Frankel, 1995; Ye et al., 1995 Ye et al., , 1996 Battiste et al., 1996; Cai et al., 1998; Legault et al., 1998) . The NMR structures of two RNA aptamer±peptide complexes (Jiang et al., 1999; Ye et al., 1999) and the identi®cation of novel RNAbinding peptides from combinatorial libraries (Harada et al., 1996 (Harada et al., , 1997 demonstrate how RNAs can help mold' the conformations of the bound peptides and further highlight the structural versatility of the argininerich RNA-binding motif. A comparison between the BIV and HIV Tat±TAR complexes also shows how two RNA sites that are virtually superimposable in structure can be recognized by arginine-rich peptides using entirely different binding strategies; the BIV and HIV complexes use different peptide conformations and amino acid±RNA interactions for recognition and, in addition, the HIV interaction also requires a cellular protein, cyclin T1, for high-af®nity binding (Smith et al., 1998 (Smith et al., , 2000 Wei et al., 1998; Bogerd et al., 2000) .
Given the versatility of the arginine-rich motif, we have been interested in exploring whether such peptides might provide reasonable starting points for the design of novel sequence-speci®c RNA binders. In previous experiments, we identi®ed arginine-rich peptides from combinatorial libraries that bind to the Rev response element (RRE) RNA with high af®nities and speci®cities but appear to bind in non-helical conformations rather than the a-helical conformation used by Rev (Harada et al., 1996 (Harada et al., , 1997 .
Structure-based design of a dimeric RNA±peptide complex
The EMBO Journal Vol. 20 No. 1 & 2 pp. 178±186, 2001 In another experiment, we used existing structural information to engineer the Rev a-helix into a zinc ®nger scaffold in order to pre-stabilize the helix prior to RNA binding, thereby generating a high-af®nity RRE-binding zinc ®nger (McColl et al., 1999) . Speci®c RRE-binding zinc ®ngers have also been identi®ed using phage display (Friesen and Darby, 1998) . To extend our structure-based design studies, we now report the construction of a dimeric RNA-binding peptide based on the NMR structure of the BIV Tat±TAR complex (Puglisi et al., 1995; Ye et al., 1995) .
The BIV Tat peptide is unstructured in the absence of RNA but adopts a b-hairpin conformation upon binding in the major groove of BIV TAR adjacent to a bulge (see Figure 1 ). Biochemical and mutagenesis experiments identi®ed eight amino acids within the 14 amino acid arginine-rich domain (three arginines, three glycines, one threonine and one isoleucine) and two G:C base pairs, an additional G nucleotide and one bulge nucleotide in BIV TAR that are essential for binding Frankel, 1994, 1995) (see Figure 1) . The NMR structure of the complex is well de®ned, and contacts between all the previously de®ned essential amino acids and bases have been observed (Puglisi et al., 1995; Ye et al., 1995) . Here we have used computer modeling to generate a plausible binding arrangement in which two covalently linked b-hairpin peptides could be bound to two adjacent TAR sites, and present evidence for the formation of a highaf®nity dimeric complex. The strategy of tethering multiple binding domains together has been used to generate DNA±protein interactions with high af®nities and speci®-cities using a variety of structural motifs (for examples see Percipalle et al., 1995; Robinson and Sauer, 1996; Kim et al., 1997; Jana et al., 1998; Kim and Pabo, 1998; Pomerantz et al., 1998; Kohler et al., 1999; Zondlo and Schepartz, 1999; Beerli et al., 2000) , and we show that similar design principles can be applied to RNA±protein interactions. In addition, we show that accessibility of the RNA major groove in vivo, as monitored by peptide binding, correlates with previous in vitro studies showing how bulged nucleotides or non-Watson±Crick base pairs can widen the major groove of A-form RNA helices and thereby enhance accessibility.
Results

Design of a dimeric RNA±peptide complex
The BIV Tat±TAR interaction is highly speci®c and forms with subnanomolar af®nity (Chen et al., 1994) . Based on the NMR structure of the complex (Puglisi et al., 1995; Ye et al., 1995) , it seemed plausible that a dimeric complex could be designed that, in principle, would interact with even higher af®nity and speci®city. As a ®rst step, we wished to determine an appropriate orientation and spacing for two TAR sites that would place the termini of the two bound b-hairpin peptides in closest proximity for bridging with a short peptide linker, reasoning that the shortest possible linker would maximally increase the effective concentration of the second RNA-binding domain after the ®rst is bound, thereby lowering the entropic cost of binding and maximally enhancing af®nity (see Kim and Pabo, 1998) . The minimal peptide-binding site in BIV TAR (see Figure 1 ) is referred to as a`half-site' in the context of the dimeric arrangements, by analogy to DNA half-sites recognized by dimeric DNA-binding proteins (see Rastinejad et al., 1995) . Three half-site orientations are possible:`head-to-head',`head-to-tail' and`tail-to-tail'. Given the b-hairpin structure of the peptide and its binding orientation, it was apparent that a head-to-head dimeric arrangement would place the peptide termini in closest possible proximity, with the N-terminus of one peptide located near the C-terminus of the second (see Figure 1) . Three spacings of the RNA half-sites seemed reasonable: D0, in which the two sites were placed directly adjacent to each other; D1, in which 1 bp separates the sites; and D2, in which 2 bp separate the sites (Figure 1 ). Residues 70±79 of the BIV Tat peptide contain all the determinants required for RNA-binding speci®city  data not shown) and, in the three head-to-head models, the distances between the C a of Arg70 and the C a of Ile79, which would be bridged by a linker, are 15.2 A Ê for D0, 17.7 A Ê for D1 and 19.9 A Ê for D2. No steric clashes were seen between the two minimal peptide units (residues Fig. 1 . Modeled structures of D0, D1 and D2 dimeric TAR RNAs with bound BIV Tat peptides, based on a single calculated NMR structure of the BIV Tat peptide±TAR complex (Puglisi et al., 1995) (shown on the left). The C a atoms of Arg70 and Ile79, to be bridged by a linker in the dimeric peptides, are shown as balls. Corresponding RNA secondary structures are also shown, where the boxed regions correspond to the minimal BIV TAR-binding site and important nucleotides de®ned by mutagenesis (Chen et al., 1994) , and the numbers indicate the critical G14:C23 base pair. The BIV Tat peptide sequence used in the NMR structure is shown on the bottom left, with important amino acids de®ned by mutagenesis highlighted in bold.
Structure-based design of a dimeric RNA±peptide complex 70±79), but some side chain clashes near the N-termini seemed possible if the peptide ends were extended (see below). Thus, the D0 TAR arrangement seemed the best choice to accommodate two minimal BIV Tat peptides bridged by the shortest linker. However, we performed some initial experiments with all three dimeric RNAs (D0, D1 and D2) to allow for imprecisions in the NMR structure and dimer site modeling.
Characterization of peptide-binding sites on the dimeric RNAs
To test whether the binding sites would be functional in the dimeric RNA context, we ®rst examined how well a monomeric BIV Tat (65±81) peptide bound the D0, D1 and D2 RNAs using gel shift assays in vitro. An RNA containing two tandem TAR hairpins designed to fold independently (2bTAR) was used as a control. As expected, two bound species were observed with 2bTAR, consistent with non-cooperative formation of one-and two-peptide complexes, but only a single peptide complex was observed with D0 ( Figure 2A ). Two peptides bound D1 only at high concentrations but readily bound D2 in which the two half-sites were spaced by 2 bp. Nearly identical results were obtained with a slightly shorter version of the peptide (residues 68±81; data not shown). The results are consistent with the modeling, suggesting that the N-termini of the two BIV Tat (68±81) peptides are in close proximity in the D0 and D1 complexes, with some potential for side chain clashes. All three dimeric RNAs bound the BIV Tat peptide with lower af®nities (~7-to 17-fold) than did 2bTAR ( Figure 2B ), suggesting that some aspect of the RNA structures was not optimal for binding, as addressed below.
We next examined binding of the BIV Tat (65±81) peptide to the dimeric RNAs in vivo using an HIV long terminal repeat (LTR)±CAT reporter system in which the RNA-binding sites were engineered into the LTR in place of HIV TAR, and the BIV Tat (65±81) peptide was fused to the activation domain of HIV Tat ( Figure 3A ) (Chen et al., 1994) . In this system, RNA binding results in transcriptional activation and CAT expression. All three dimeric reporters showed much lower activation than observed with a monomeric TAR hairpin, with activity increasingly reduced as additional base pairs were added between the two binding sites ( Figure 3B ). Thus, the dimeric reporters in general 
Accessibility of the BIV TAR major groove
We wished to understand why the dimeric RNAs bound the BIV Tat peptide so poorly and suspected that the problem might be related to the addition of contiguous base pairs adjacent to the binding site. It is known that the deep and narrow major groove of an A-form RNA helix is relatively inaccessible for protein binding unless the helix is interrupted by discontinuities such as bulges or nonWatson±Crick pairs, or is located adjacent to a loop (Weeks and Crothers, 1993) . Single nucleotide bulges, such as those found in BIV TAR, only marginally widen the major groove, and we presumed that close proximity of the binding site to the loop might be important to create a groove suf®ciently wide for binding. To test this hypothesis, we constructed a series of reporters containing 1±5 additional base pairs in the upper stem of a monomeric TAR site, expected to decrease groove accessibility incrementally (Figure 4 ), and measured activation by the HIV±BIV Tat (65±81) fusion protein. The sequence of base pairs added corresponds to that in the D0 RNA to allow a rough comparison between the monomer and dimer structures. As shown in Figure 4 , activation decreased as an increasing number of pairs was added, reaching a 200-fold decrease when ®ve additional pairs were added. To examine whether peptide binding in vitro also correlated with the postulated differences in groove accessibility, we performed gel shift assays with bTAR0, bTAR2 and bTAR5, containing zero, two or ®ve additional base pairs between the binding site and the loop, respectively ( Figure 5A ). We observed a 2-to 6-fold decrease in af®nity as additional pairs were added ( Figure 5B ), further suggesting that the major groove becomes less accessible to peptide binding as the upper helix is lengthened. As observed with the dimeric RNAs described above, considerably larger decreases were observed by the in vivo activation assays than the gel shift assays, perhaps re¯ecting less hindrance to binding of the short peptide than the fusion protein, which contains the tethered Tat activation domain, or re¯ecting interference of binding of other cellular proteins such as cyclin T1 (Wei et al., 1998) . The difference in magnitude is unlikely to re¯ect the different temperatures of the two assays (4°C in vitro versus 37°C in vivo) as binding assays performed at higher temperatures produced similar binding constants (data not shown).
To provide further evidence that the reduced activation observed in vivo probably results from decreased major groove accessibility, we designed a series of reporters with reopened' RNA structures and monitored activation by the HIV±BIV Tat (65±81) fusion protein. A previous in vitro study used diethylpyrocarbonate reactivity to monitor accessibility of RNA helices containing a systematic series of unpaired nucleotides (Weeks and Crothers, 1993) . We engineered a similar set of bulges, asymmetric loops and symmetric loops into the upper stem of bTAR5, as well as two additional RNAs with bulges in the lower stem, to test the accessibility hypothesis ( Figure 6 ). In general, bulges or asymmetric loops containing two or more unpaired nucleotides in the upper stem restored activity substantially, correlating well with the major groove accessibilities previously observed in vitro (Weeks and Crothers, 1993) . A two-nucleotide bulge introduced into the lower stem had little effect, whether or not the upper stem contained a bulge (Figure 6 ). We attempted to engineer Structure-based design of a dimeric RNA±peptide complex different nucleotides and additional types of bulges into the lower stem; however, the surrounding sequence led to many alternative base pairing possibilities and precluded a systematic analysis. The best con®guration in the upper stem contained an asymmetric loop with three nucleotides on one strand and ®ve on the other, and increased activation >75-fold compared with the fully paired bTAR5 (Figure 6 ). Thus, adding base pairs to the upper stem of BIV TAR substantially decreases BIV Tat peptide binding, whereas introducing unpaired nucleotides in con®gurations known to enhance major groove accessibility restores binding. Although we have not measured groove accessibility directly, and other possible differences in helical structure undoubtedly can affect peptide binding, the strong correlation between our in vivo binding results and the published in vitro results (Weeks and Crothers, 1993) suggests that inaccessibility of the major groove is at least one probable factor contributing to poor binding by the dimeric RNAs.
Design of BIV Tat peptide dimers As described in the modeling section above, the ends of the two peptide b-hairpins are predicted to be in closest proximity in the D0 arrangement and thus D0 RNA appeared to be the best candidate for binding a dimeric peptide. Of the dimeric RNAs examined, D0 also showed the highest af®nity for the monomeric BIV Tat peptide in vitro, was able to bind two N-terminally truncated peptides (residues 70±81; data not shown) simultaneously, and had the highest reporter activity and presumably most accessible major groove of the dimeric RNAs tested in vivo. To design an appropriate peptide dimer, we ®rst considered the distance between the a carbons of Arg70 and Ile79 in the D0 complex (15.2 A Ê ) and, assuming an extended peptide chain of 3.5 A Ê /residue, we reasoned that a six-amino-acid linker would be short enough to gain much of the entropic bene®t of tethering yet still allow some degree of¯exibility. We initially used six glycine residues [BIV dimer(G6) ; see Figure 7 ] to help maximize¯exibility and minimize possible side chain steric clashes. The charge of a dimeric peptide containing two BIV Tat 70±79 units and an uncharged linker (see Figure 7) was only slightly greater than that of the BIV Tat (65±81) monomer used as a control (+10 versus +8) and thus was expected to enhance non-speci®c binding modestly. We also designed another dimer in which the sequence of the ®rst BIV Tat RNA-binding domain was extended with the natural sequence found in BIV Tat (BIV dimer ; see Figure 7 ). This second dimer was used for in vivo experiments as well as in vitro experiments, as described below.
Dimeric RNA±peptide binding in vitro
In principle, forming a covalent dimer could enhance speci®c RNA-binding af®nity by as much as the square of the binding constants (or the sum of the free energies) if the designed dimer was rigid and perfectly oriented. For DNA-binding proteins, covalent¯exible linkage of binding domains has resulted in af®nities generally enhanced by two or three orders of magnitude (for examples see Percipalle et al., 1995; Robinson et al., 1996; Kim et al., 1997; Jana et al., 1998; Kim and Pabo, 1998; Pomerantz et al., 1998; Kohler et al., 1999; Zondlo et al., 1999; Beerli et al., 2000) . In our case, the designed BIV dimer(G6) and BIV dimer peptides bound the D0 dimeric RNA in vitro with apparent K d values of~0.5 nM compared with 6 nM for the monomeric BIV Tat (65±81) peptide (Figure 7) . In contrast, the dimeric peptides bound to the 2bTAR dimeric RNA composed of two independent hairpins with~5 nM af®nities, even weaker than the binding of the monomeric BIV Tat (65±81) peptide.
To test whether both half-sites are required for highaf®nity binding to the dimeric RNA hairpin and to assess speci®city, we generated mutant D0 RNAs in which an essential G14:C23 base pair (see Figure 1 ; Chen et al., 1994) was changed to C:G in one or both of the sites. Introducing this mutation into either single site reduced the binding af®nity of both the BIV dimer(G6) and BIV dimer peptides~10-fold in each case, consistent with binding to a single site, whereas mutation of both sites abolished binding (the data in Figure 7 show K d values >50 nM and data not shown indicate K d values >1 mM), demonstrating that binding is highly speci®c. The binding af®nity of the BIV Tat (65±81) peptide for each single site mutant decreased~2-fold compared with D0, perhaps re¯ecting the entropic loss of removing one of two possible binding sites and/or communication between the half-sites upon peptide binding. The binding af®nities of the dimeric peptides for the single site mutants remain 2-to 5-fold higher than for the monomeric peptide, perhaps re¯ecting some degree of non-speci®c binding by the dimeric peptides. The requirement for both half-sites to achieve high-af®nity binding of the peptide dimers supports the proposed dimeric binding mode.
Dimeric RNA±peptide binding in vivo
Given the high af®nity of the dimeric interaction observed in vitro, we next wished to compare activation of dimeric and monomeric constructs in vivo. Initial experiments using the Tat activation domain fused to the BIV dimer(G6) peptide showed no activity on any of the reporter constructs tested (data not shown), including the highly activatible monomeric BIV TAR reporter. This result may possibly be explained by poor protein expression or stability. However, the second dimeric peptide, which utilizes a linker with the natural sequence of BIV Tat C-terminal to the RNA-binding domain (Figure 8 ), was 20-fold more active on the D0 dimer RNA reporter than was the monomeric BIV Tat (65±81) peptide (Figure 8 ), suggesting a much higher af®nity dimeric interaction. In contrast, both the monomer and dimer peptides were equally active on the 2bTAR reporter containing two independent hairpins. The overall levels of activation with the 2bTAR reporter were higher than with D0, probably due to the differences in major groove accessibility, as described above.
To examine further the speci®city of the dimeric interaction and to test whether both units of the peptide dimer are needed for activity, we generated mutants in one or both halves of the peptide dimer. Introducing Arg73 to lysine mutations known to abolish speci®c RNA binding into either the N-or C-terminal RNAbinding domain strongly reduced activity on the D0 dimeric RNA reporter, reducing activity to the weak level observed with the monomeric BIV Tat (65±81) fusion protein on the D0 reporter (Figure 8) . A slight amount of residual activity was observed with the double mutant peptide, perhaps re¯ecting a small degree of non-speci®c binding. The requirement for both halves of the peptide dimer for high-af®nity binding to the dimeric RNA in vivo is consistent with the modeled dimeric interaction.
Discussion
To our knowledge, these studies provide the ®rst example of the design of a speci®c RNA-binding dimer. There are numerous examples in which enhanced DNA-binding af®nity and/or extended speci®city have been achieved by covalently tethering two or more DNA-binding modules (for examples see Percipalle et al., 1995; Robinson et al., 1996; Kim et al., 1997; Jana et al., 1998; Kim and Pabo, 1998; Pomerantz et al., 1998; Kohler et al., 1999; Zondlo et al., 1999; Beerli et al., 2000) , in some cases by creating a covalent linkage between two subunits of a normally dimeric protein. In simplistic terms, the DNA recognition surface in these cases may be thought of as a linear DNA helix, with the¯exible covalent linker between protein modules used to generate a high local concentration of the second domain upon binding of the ®rst. Many dimeric DNA-binding proteins, however, achieve recognition of their dimeric sites not simply by a tethering mechanism but also by forming highly ordered dimerization interfaces that are structurally matched to the arrangements of the DNA half-sites (Rastinejad et al., 1995) . This latter situation represents a better analogy to the designed BIV Tat±TAR dimer in which the orientation of half-sites appears critical; the high-af®nity interaction occurs only with the D0 RNA dimer and not when two independently Fig. 7 . Binding of the BIV Tat (65±81) , BIV dimer(G6) and BIV dimer peptides to dimeric TAR RNAs and RNA mutants in vitro. Gel shift assays were performed with 0.02 nM RNA at the peptide concentrations indicated (nM). D0 a contains the G14:C23 to C:G mutation (see Figure 1 ; Chen et al., 1994) in the upper binding site, D0 b contains the mutation in the lower site and D0 ab contains the mutation in both sites.
Structure-based design of a dimeric RNA±peptide complex folded TAR hairpins are tethered. For some DNA-binding proteins, such as the nuclear receptors, the dimerization interface becomes ordered only after interacting with DNA, leading to cooperative binding to the two half sites (Rastinejad et al., 1995) . A similar case of cooperative binding has been observed with a U1A RNP domain±RNA complex in which binding of one RNP domain to an internal loop in the 3¢-untranslated region of its own mRNA stabilizes a C-terminal helix, which then interacts with an adjacent RNP subunit bound at an identical loop (Varani et al., 2000) .
Because RNA-binding sites typically contain bulges, loops and non-Watson±Crick base pairs, and are not composed of simple helices, it can be dif®cult to predict the spatial orientations of two half-sites. To make the design of dimeric RNA±protein interactions even more challenging, alternative RNA structures may be formed when two identical sites are juxtaposed, and problems relating to the size and shape of the¯anking helical regions may arise, such as accessibility of the major groove as described here. Nonetheless, it may be possible to optimize the positioning of two RNA half-sites, perhaps including intervening bulges, as well as the nature of the protein linkers using combinatorial selection experiments to identify high-af®nity sequence-speci®c interactions (Laird-Offringa and Belasco, 1995; Harada et al., 1996 Harada et al., , 1997 Friesen et al., 1998; Tan and Frankel, 1998) . The structures of the MS2 coat protein bound to its operator RNA and a series of RNA aptamers show that a dimeric RNA-binding protein can recognize two`pseudo' halfsites in which a bulge nucleotide in one`half-site' and a loop nucleotide in the other`half-site' are bound in similar ways, with subtle differences in the interactions with each site (Valegard et al., 1994; Rowsell et al., 1998) . Given that dimeric complexes need not be symmetric, it seems plausible that new dimeric RNA±protein interactions with desired speci®cities may be designed by starting with onè anchored' interaction to identify tethered peptides that interact speci®cally with an adjacent second site, and then identifying linkers that match the orientation of two peptide units more precisely to a particular con®guration of the two binding sites, such as the D0 TAR con®guration described here. In our initial BIV Tat±TAR experiments, we joined the domains with very simple linkers that almost certainly can be optimized better, potentially even introducing additional interactions to the RNA. Combinatorial experiments with Arc repressor and zinc ®ngers have been used both to optimize the linkers between two domains and to generate new DNA-binding speci®cities of the appended domains (Greisman and Pabo, 1997; Robinson and Sauer, 1998 ). The dimeric peptides described here provide a reasonable starting point for the further design of high-af®nity RNA-binding peptides that bind therapeutically important RNA sites or that might be used to deliver proteins to speci®c RNAs.
In the case of our designed BIV Tat dimer, we presume that the peptide is disordered in the absence of BIV TAR, like the monomeric peptide, and folds into a double b-hairpin structure upon binding (see Figure 1 ), although we currently have no direct evidence for the structure. This putative coupled binding and folding is unlike most tethered DNA-binding interactions in which each domain is folded largely independently, with basic region leucine zipper and basic region helix±loop±helix proteins being notable exceptions (see Ellenberger, 1994) . It may be possible to enhance RNA-binding af®nity and/or speci®-city of the BIV complex further by pre-stabilizing the b-hairpin structure prior to binding, as was done with the a-helical RNA-binding domain of Rev (Tan et al., 1993; McColl et al., 1999) , provided that a conformational change is not needed to ®t the BIV peptide into its RNA site. Additional structural studies of the BIV dimeric complex, identi®cation of other tight-binding peptides from arginine-rich combinatorial libraries in which the peptide conformation might be stabilized and studies of peptides engineered with non-natural amino acids or chemical linkers that stabilize the b-hairpin may shed further light on the coupled folding problem.
One unexpected observation in our studies was the apparently poor major groove accessibility of the dimeric RNAs, particularly when assayed in vivo. When the two half-sites were placed in adjacent con®gurations, contiguous helices of 6, 7 or 8 bp were formed between the closest bulged uridines in each binding site (see Figure 1) . Previous in vitro studies suggested that uninterrupted helices of perhaps as many as 8 bp could be accessed via the effective`ends' created by adjacent bulges or loops (Weeks and Crothers, 1993) , but it appears that the single bulge nucleotides in the BIV TAR con®guration alone do not generate suf®cient accessibility for peptide binding. The observation that the dimeric RNAs were relatively inactive provided an opportunity to use BIV Tat peptide binding as a probe for major groove accessibility in vivo. By engineering bulges and loops into an extended BIV TAR helix (Figure 4) , we found an excellent correlation between RNA structures known to generate major groove accessibility in vitro and those that promote BIV Tat peptide binding in vivo. It is interesting that asymmetric bulges and loops that contain extra nucleotides on the 5¢ side of the peptide-binding site appear to create much more accessible grooves than when extra nucleotides are located 3¢ to the site (Figure 6 ). BIV TAR contains two single nucleotide bulges that may already make the site partially accessible even when embedded in a long duplex. It seems reasonable that bulges introduced into the opposite strand would enhance access to the site further, with nucleotides on the 5¢ side that make critical contacts to Gly71 and Thr72 of the b-hairpin peptide expected to become the most accessible (Weeks and Crothers, 1993) . Thus, the BIV interaction provides a glimpse into RNA major groove accessibility in vivo, at least in one particular structural context.
Materials and methods
Modeling Models for possible con®gurations of dimeric BIV TAR-binding sites were constructed using the Insight II graphics program (Biosym) on a Silicon Graphics workstation. Coordinates of a single BIV Tat±TAR NMR model (structure number 6; Puglisi et al., 1995) were used to explore various orientations of the two`half-sites' in a dimer. This particular NMR model was chosen because it contained a well-formed U±A:U base triple, in agreement with observations by Patel and colleagues (Ye et al., 1995) , and because it displayed most of the important RNA±peptide contacts. To model the dimeric RNAs with binding sites in three different orientations (`head-to-head',`head-to-tail' and`tail-to-tail'), the four-nucleotide BIV TAR hairpin loop was removed and the two RNA sites were positioned by visually overlapping the two end base pairs of each site. To model the`head-to-head' dimeric RNAs more accurately, the orientation of`half-sites' was approximated by generating 6 bp of an idealized A-form RNA helix and using this helix as a`splint' to minimize the r.m.s. values of four phosphate groups (5¢ to G14, C15, G22 and C23) at the ends of each of the TAR sites. To test whether any of the modeled RNA arrangements were likely to adopt alternative structures, all designs were run through the MFOLD secondary structure prediction algorithm (Zuker, 1989) , and no reasonable alternative folds were found in any of the cases.
Peptide synthesis, puri®cation and analysis Peptides were synthesized on an Applied Biosystems model 432A peptide synthesizer using standard Fmoc chemistry and resins. The N-terminus of each peptide was acetylated using acetic anhydride, and the use of amidated resin resulted in amidated C-termini after cleavage. Peptides were puri®ed by C 4 reverse-phase HPLC (Vydac) using an acetonitrile gradient of 0.2%/min in 0.1% tri¯uoroacetic acid. The molecular weights of the peptides were obtained by laser desorption mass spectrometry, and peptide concentrations were determined by quantitative amino acid analysis (University of Michigan Protein and Carbohydrate Structure Facility). Peptide purity and concentrations were con®rmed using native PAGE with Coomassie Blue staining. The sequence of the BIV Tat (65±81) peptide is ac-SGPRPRGTRGKGRRIRR-am, the sequence of the BIV dimer(G6) peptide is ac-GRGTRGKGRRIGGGGGGRGTRGKGR-RIG-am, and the sequence of the BIV dimer peptide is ac-SGPRPRGTR-GKGRRIRRTASGRGTRGKGRRIRR-am.
RNA-binding gel shift assays
Internally labeled RNAs were prepared by in vitro transcription using T7 polymerase and [a-32 P]CTP. RNA concentrations were determined by measuring incorporation of the isotope and calculating speci®c activities. RNAs were annealed by heating to 90°C and slow cooling to room temperature in renaturation buffer (10 mM Tris pH 7.5, 100 mM NaCl) at RNA concentrations of 5±20 nM. The binding reactions shown in the ®gures were carried out in 10 mM HEPES±KOH pH 7.5 buffer containing 100 mM KCl, 1 mM MgCl 2 , 0.5 mM EDTA, 1 mM dithiothreitol, 10% glycerol, and 50 mg of tRNA as a competitor. Additional binding reactions (not shown) were carried out in 10 mM Tris±HCl pH 7.5, 70 mM NaCl, 0.2 mM EDTA and 25 mg/ml yeast tRNA as a competitor, and similar results were obtained. Reactions were incubated on ice for 10 min, loaded onto pre-run 20% native polyacrylamide gels (in 0.5Q TBE buffer), and electrophoresed at 200 V at 4°C. For quantitation, dried gels were autoradiographed and scanned or exposed to a phosphorimaging plate and scanned with a Molecular Dynamics PhosphorImager, and free and bound RNA bands were quanti®ed using ImageQuant software. To calculate apparent binding constants, the fraction of bound RNA was estimated by measuring the disappearance of the unbound band. This was necessary to normalize for differences among the different RNAs in the number of potential binding sites and variable numbers of complexes. For example, while 2bTAR and D2 are able to bind two monomeric BIV Tat peptides, D0 can bind only one peptide even though it contains two potential binding sites (see Results), and bTAR contains just a single binding site. Binding curves were ®t to the data using Kaleidagraph software (Synergy Software, Reading, PA) and standard binding equations. For RNAs that showed singly and doubly bound species, in some cases we also calculated apparent binding constants by directly quantitating the bound bands and ®tting the data to single binding isotherms, approximating the fraction of bound sites as the sum of the singly bound species and one half of the doubly bound species. Apparent binding constants estimated by both methods were in reasonable agreement, but because ®tting errors were generally higher using the second method and because direct comparisons between RNAs with different numbers of binding sites are dif®cult, binding constant data are presented from calculations based on the disappearance of unbound RNAs.
Plasmid construction and CAT assays HIV±BIV Tat hybrids were constructed by cloning synthetic oligonucleotide cassettes encoding each peptide directly after the codon for residue 49 of HIV-1 Tat in the pSV2tat72 expression vector (Tan et al., 1998) , thereby replacing the C-terminal residues in HIV-1 Tat, including its own RNA-binding domain, with heterologous RNA-binding peptides. BIV TAR-related reporters were constructed by cloning oligonucleotide cassettes into an HIV-1 LTR±CAT reporter plasmid as described (Tao and Frankel, 1993) . Reporter and expressor plasmids were transiently cotransfected into HeLa cells using lipofectin and Optimem media (Gibco-BRL). Total DNA amounts were adjusted to 1 mg per transfection using pUC19 plasmid DNA. Cells were harvested 44 h after transfection, and CAT activities were assayed as described (Tan et al., 1993) and quanti®ed using a Molecular Dynamics PhosphorImager.
